Suven Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: SUVENPHAR | BSE: 543064
₹1,088.00 -37.20 (-3.31 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 1,126.80
High (₹) 1,135.00
Low (₹) 1,076.50
Prev. Close (₹) 1,125.20
Volume 1,88,950
VWAP (₹) 1,192.59
ROCE (%) 19.24
Industry P/E 44.73
TTM P/E 99.18
P/B Ratio 13.51
Market Cap (₹) Cr.27,696.67
Dividend Yield (%)--
EPS (₹) 11.80
ROE14.65%
Sales Growth (%) -21.56
Profit Growth (%)-26.99
Day Range
1,135.001,135.00
52 Week Range
597.001,359.00
Historical Returns
Returns (6M)
-6.25 %
Returns (1Y)
67.85 %
Returns (3Y)
79.21 %
Returns (5Y)
724.24 %
Returns (6M)
-6.25 %
Returns (1Y)
67.85 %
Returns (3Y)
79.21 %
Returns (5Y)
724.24 %
SWOT Analysis
- Company with Low Debt
- Book value per share improving over the last 2 years
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
Technicals
Technical Rating
RSI 62.45
MFI 83.71
ATR 78.54
Commodity Channel Index 83.83
ROC125 14.34
ROC21 17.03
Williams %R -37.39
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 1,263.60 | 1,312.50 | 1,383.15 | 1,192.95 | 1,144.05 | 1,073.40 | 1,024.50 |
Week Ago | 1,247.24 | 1,268.02 | 1,303.74 | 1,211.52 | 1,190.74 | 1,155.02 | 1,134.24 |
Month Ago | 997.74 | 1,020.17 | 1,051.54 | 966.37 | 943.94 | 912.57 | 890.14 |
EMA & SMA
1088.00
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 1211.70
9 Day 1166.94
10 Day 1155.33
12 Day 1140.78
14 Day 1143.66
20 Day 1139.73
26 Day 1105.03
50 Day 1116.39
100 Day 1189.11
200 Day 1044.34
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
AMANSA HOLDINGS PRIVATE LIMITED | bulk | Sell | 01 Mar, 2024 | ₹689.19 | 31,26,653 | NSE |
ABU DHABI INVESTMENT AUTHORITY STABLE | bulk | Buy | 01 Mar, 2024 | ₹698.15 | 15,74,000 | NSE |
RAMBABU CHIRUMAMILLA | bulk | Sell | 14 Sept, 2023 | ₹530.68 | 38,08,386 | NSE |
ALPHA ALTERNATIVES MSAR LLP | bulk | Sell | 16 Aug, 2023 | ₹520.02 | 20,91,000 | NSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹450.95 | 27,580 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹450.95 | 2,44,540 | NSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹450.95 | 27,580 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹450.95 | 2,44,540 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
30 Sept, 2023 | JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED in its capacity as sole Trustee of the Jasti Family Trust | Disposal | ₹495.00 | 12,75,37,043 | NSE |
14 Aug, 2023 | PADMAJA J.A.S | Disposal | ₹501.77 | 28,000 | NSE |
17 Feb, 2023 | PADMAJA J.A.S | Disposal | ₹482.25 | 7,000 | NSE |
02 Sept, 2020 | PADMAJA J.A.S | Acquisition | ₹640.64 | 5,000 | NSE |
31 Aug, 2020 | PADMAJA J.A.S | Acquisition | ₹688.15 | 2,500 | NSE |
27 Aug, 2020 | PADMAJA J.A.S | Acquisition | ₹702.80 | 5,000 | NSE |
24 Aug, 2020 | PADMAJA J.A.S | Acquisition | ₹685.74 | 5,000 | NSE |
04 Jul, 2020 | PADMA KUMAR R | Acquisition | ₹470.31 | 10,000 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
30 Aug, 2022 | Rs.5.0000 per share(500%)Special Dividend | 09 Sept, 2022 | 12 Sept, 2022 |
29 Aug, 2022 | Rs.1.0000 per share(100%)Interim Dividend | 09 Sept, 2022 | 12 Sept, 2022 |
03 May, 2022 | Rs.1.0000 per share(100%)Special Dividend | 13 May, 2022 | 17 May, 2022 |
17 Aug, 2020 | Bonus issue in the ratio of 1:1 of Re. 1/-. | 25 Sept, 2020 | 28 Sept, 2020 |
Announcements
Date | Source | Detail |
---|---|---|
02 Apr, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange about General Updates |
01 Apr, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange about General Updates |
01 Apr, 2025 | BSE India | Cautionary email received from the stock exchange |
28 Mar, 2025 | NSE India | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
28 Mar, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Subba Raju Komaravolu as Senior Management Personnel of the company w.e.f. closing of working hours on March 31, 2025. |
28 Mar, 2025 | BSE India | Resignation of Senior Management Personnel |
27 Mar, 2025 | NSE India | Suven Pharmaceuticals Limited has informed the Exchange regarding ''Update on merger''. |
27 Mar, 2025 | BSE India | Update on Merger |
27 Mar, 2025 | NSE India | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window |
27 Mar, 2025 | NSE India | SUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2025 . |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Audited Results | -- | 28 Mar, 2025 | 28 May, 2025 |
Quarterly Results | -- | 28 Dec, 2024 | 12 Feb, 2025 |
Quarterly Results | -- | 01 Oct, 2024 | 12 Nov, 2024 |
Quarterly Results | -- | 05 Aug, 2024 | 09 Aug, 2024 |
Audited Results | (Revised) | 22 May, 2024 | 30 May, 2024 |
Quarterly Results | -- | 22 May, 2024 | 05 Feb, 2024 |
Quarterly Results | -- | 03 Nov, 2023 | 09 Nov, 2023 |
Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
Audited Results | -- | 19 May, 2023 | 25 May, 2023 |
Quarterly Results | -- | 31 Jan, 2023 | 06 Feb, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 50.1% | 60% | 60% | 60% | 60% |
Foreign Institutions + | 10.84% | 10.14% | 8.11% | 8.25% | 6.04% |
Domestic Institutions + | 16.67% | 15.94% | 11.36% | 5.93% | 4.65% |
Government | 0.01% | 0.01% | 0% | 0% | 0% |
Public | 22.38% | 13.91% | 20.53% | 25.82% | 29.31% |
Others | 0% | 0% | 0% | 0% | 0% |
About Suven Pharmaceuticals
Suven Pharmaceuticals is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1024.99 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
2018
Managing Director
Dr. V Prasada Raju
NSE Symbol
SUVENPHAR
Suven Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Annaswamy Vaidheesh | Executive Chairperson |
Dr. V Prasada Raju | Managing Director |
Mr. Pankaj Patwari | Non Executive Director |
Ms. Shweta Jalan | Non Executive Director |
Ms. Matangi Gowrishankar | Independent Director |
Mr. Vinod Rao | Independent Director |
Mr. K G Ananthakrishnan | Independent Director |
Mr. Pravin Rao Udhyavara Bhadya | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Suven Pharmaceuticals
What is the share price of Suven Pharmaceuticals?
The share price of Suven Pharmaceuticals on 04 Apr, 2025 is ₹ 1,088.00.
What is 52W high and 52W low share price of Suven Pharmaceuticals?
The highest and lowest 52W share prices of Suven Pharmaceuticals are ₹ 1359.000 and ₹ 597.000
What is the market cap of Suven Pharmaceuticals?
The market capitalization of Suven Pharmaceuticals as of 04 Apr, 2025 is ₹ 27,696.67 Crores
What is the P/E ratio of Suven Pharmaceuticals?
The current P/E ratio of Suven Pharmaceuticals as of 04 Apr, 2025 is 44.73
What is the PB ratio of Suven Pharmaceuticals?
The PB ratio of Suven Pharmaceuticals as of 04 Apr, 2025 is 13.51
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)